Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Giovanni Di Perri and Tommaso Lupia.
Giovanni Di Perri
Connection Strength
0.875
Tommaso Lupia
  1. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. J Glob Antimicrob Resist. 2020 06; 21:22-27.
    View in: PubMed
    Score: 0.218
  2. Efficacy and safety of interferon-free regimens in patients affected by chronic hepatitis C and psychiatric disorders. J Infect Chemother. 2020 Jan; 26(1):18-22.
    View in: PubMed
    Score: 0.208
  3. Antiviral treatment with pegylated interferon and clinical outcomes in a cohort of immigrants patients affected by hepatitis delta: A retrospective analysis. J Med Virol. 2019 07; 91(7):1329-1334.
    View in: PubMed
    Score: 0.203
  4. Retreatment with sofosbuvir/velpatasvir in cirrhotic patients with genotype-4 who failed a previous interferon-free regimen: a case series. Antivir Ther. 2018; 23(6):543-547.
    View in: PubMed
    Score: 0.187
  5. Risk Factors for Mortality in COVID-19 Hospitalized Patients in Piedmont, Italy: Results from the Multicenter, Regional, CORACLE Registry. J Clin Med. 2021 May 01; 10(9).
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.